1 |
FRIEDRICH M J. Depression Is the Leading Cause of Disability Around the World[J]. JAMA,2017,317(15):1517-1520. doi:10.1001/jama.2017.3826
doi: 10.1001/jama.2017.3826
|
2 |
BANDOSZ P, AHMADI-ABHARI S, GUZMAN-CASTILLO M. Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study[J]. Diabetologia, 2020,63(1):104-115. doi:10.1007/s00125-019-05015-4
doi: 10.1007/s00125-019-05015-4
|
3 |
MARTINY K. Novel Augmentation Strategies in Major Depression[J]. Dan Med J, 2017,64(4): B5338.
|
4 |
DHIR A. Investigational drugs for treating major depressive disorder[J]. ExPert OPin Investig Drugs, 2017,26(1):9-24. doi:10.1080/13543784.2017.1267727
doi: 10.1080/13543784.2017.1267727
|
5 |
LEE G,BAE H. Therapeutic effects of phytochemicals and medicinal herbs on depression [J]. Biomed Res Int, 2017,5(6):6596241.
|
6 |
赵培源,陈少昀,刘喜红. lncRNA与miRNA相互作用对中枢神经系统发育的影响[J]. 实用医学杂志, 2022,38(18):2373-2376.
|
7 |
ŻURAWEK D, TURECKI G. The miRNome of Depression[J]. Int J Mol Sci, 2021,22(21):11312-11320. doi:10.3390/ijms222111312
doi: 10.3390/ijms222111312
|
8 |
LOPEZ J P,KOS A, TURECKI G. Major depression and its treatment: microRNAs as Peripheral biomarkers of diagnosis and treatment response[J]. Curr Opin Psychiatry, 2018,31(1):7-16. doi:10.1097/yco.0000000000000379
doi: 10.1097/yco.0000000000000379
|
9 |
PENNER-GOEKE S, BINDER E B. Epigenetics and depression[J]. Dialogues Clin Neuro sci, 2019,21(4):397-405. doi:10.31887/dcns.2019.21.4/ebinder
doi: 10.31887/dcns.2019.21.4/ebinder
|
10 |
陈华琴,王谨敏. 外泌体microRNA在抑郁症中的研究进展及应用前景[J]. 中国现代医药杂志, 2023,25(4):95-99. doi:10.3969/j.issn.1672-9463.2023.04.022
doi: 10.3969/j.issn.1672-9463.2023.04.022
|
11 |
FAROOQI A A, QURESHI M Z, COSKUNPINAR E, et al. MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis[J]. Asian Pac J Cancer Prev, 2014,15(5):1909-1912. doi:10.7314/apjcp.2014.15.5.1909
doi: 10.7314/apjcp.2014.15.5.1909
|
12 |
WANG J, ZHANG Y, XU Q,et al. Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells[J]. Oncotarget, 2017,8(11):18082-18094. doi:10.18632/oncotarget.14993
doi: 10.18632/oncotarget.14993
|
13 |
汤光花,陈永新,张瑞岭. 舒肝颗粒对抑郁大鼠海马神经元凋亡、脑组织caspase-3蛋白及外周血中细胞因子水平的影响[J]. 中国老年学杂志, 2018,38(1):52-54. doi:10.3969/j.issn.1005-9202.2018.01.020
doi: 10.3969/j.issn.1005-9202.2018.01.020
|
14 |
TANIGUTI E H, FERREIRA Y S, STUPP I J V,et al.Atorvastatin prevents lipopolysaccharide-induced depressive-like beha-viour in mice[J]. Brain Res Bull, 2019,146:279. doi:10.1016/j.brainresbull.2019.01.018
doi: 10.1016/j.brainresbull.2019.01.018
|
15 |
高玉广,马玉娟,莫穷泽,等. miR-34a抑制BCL-2激活NLRP1炎症小体诱导大鼠癫痫的发生[J]. 海南医学院学报, 2023,29(1):15-22.
|
16 |
李静,韩永凯,苏静,等. miR-134调控CREB/BDNF通路参与脑卒中后抑郁的作用机制研究[J]. 天津医药, 2021,49(1):16-21.
|
17 |
高玉广,黄德庆,刘泰,等. 健神利水方对脑出血大鼠水通道蛋白AQP-4表达的影响[J]. 中国民族民间医药, 2021,30(5):17-20. doi:10.3969/j.issn.1007-8517.2021.5.zgmzmjyyzz202105007
doi: 10.3969/j.issn.1007-8517.2021.5.zgmzmjyyzz202105007
|
18 |
LI Y, SONG W, TONG Y,et al. Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis[J]. J Neuroinflammation, 2021,18(1):1. doi:10.1186/s12974-020-02040-8
doi: 10.1186/s12974-020-02040-8
|
19 |
SHIM D W, LEE K H.P osttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome[J]. Front Immunol, 2018,9:1054. doi:10.3389/fimmu.2018.01054
doi: 10.3389/fimmu.2018.01054
|
20 |
SU W J, ZHANG Y, CHEN Y,et al.NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model[J]. Behav Brain Res, 2017,322(Pt A):1-8. doi:10.1016/j.bbr.2017.01.018
doi: 10.1016/j.bbr.2017.01.018
|
21 |
MILLER A H, RAISON C L. The role of inflammation in dePression:from evolutionary imPerative to modern treatment target[J]. Nat Rev Immunol, 2016,16(1):22-34. doi:10.1038/nri.2015.5
doi: 10.1038/nri.2015.5
|
22 |
BEUREL E, TOUPS M, NEMEROFF C B. The Bidirectional Relationship of Depression and Inflammation: Double Trouble[J]. Neuron, 2020,107(2):234-256. doi:10.1016/j.neuron.2020.06.002
doi: 10.1016/j.neuron.2020.06.002
|
23 |
KUANG W H, DONG Z Q, TIAN L T,et al. MicroRNA-451a,microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment[J].Braz J Med Biol Res, 2018,51(7):e7212. doi:10.1590/1414-431x20187212
doi: 10.1590/1414-431x20187212
|
24 |
ZHOU M, WANG M, WANG X,et al. Abnormal Expression of MicroRNAs Induced by Chronic Unpredictable Mild Stress in Rat Hippocampal Tissues[J]. Mol Neurobiol, 2018,55(2):917-935. doi:10.1007/s12035-016-0365-6
doi: 10.1007/s12035-016-0365-6
|
25 |
LIN C C, TSAI M C, LEE C T,et al.Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder[J]. Psychiatry Res,2018,270:232-237. doi:10.1016/j.psychres.2018.09.025
doi: 10.1016/j.psychres.2018.09.025
|
26 |
MIAO C, CHANG J. The important roles of microRNAs in depression: new research progress and future prospects[J]. J Mol Med (Berl), 2021,99(5):619-636. doi:10.1007/s00109-021-02052-8
doi: 10.1007/s00109-021-02052-8
|